MEI Pharma Investor Presentation — September 2021

Document content

Developing Best -in-Class Cancer Therapies

H.C. Wainwright 23rd Annual Global Investment Conference

September 13 -15, 2021This presentation contains, and our officers and

representatives may from time to time make,

statements that are “forward -looking

statements” within the meaning of the safe

harbor provisions of the U.S. Private Securities

Litigation Reform Act of 1995.

Examples of forward -looking statements

include, among others, statements regarding

our development strategy; potential advantages

of our product candidates; the initiation and

completion of preclinical and clinical studies

and the reporting of the results thereof; the

timing of regulatory submissions and actions;

the sufficiency of our existing cash; and all

other statements relating to our plans,

objectives, expectations and beliefs regarding

future performance, operations, financial

condition and other future events (including

assumptions underlying or relating to any of the

foregoing). These forward -looking statements rely on a

number of assumptions concerning future

events and are subject to a number of risks,

uncertainties, and other factors, many of which

are outside of our control. Important factors

that could cause our actual results and financial

condition to differ materially from those

indicated in forward -looking statements include,

among others: uncertainties relating to the

Preview truncated — download the full document for the complete content.